Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

NCT05769582 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

BK Viremia; BKV DNAemia

Interventions

BIOLOGICAL: Anti-BK polyomavirus (AntiBKV)

Sponsor

Memo Therapeutics AG